Lea Dousset

Bordeaux, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Eosinophilic fasciitis induced by checkpoint inhibitors: A retrospective multicenter case series, comparison with eosinophilic fasciitis unrelated to checkpoint inhibition and literature review.

Eosinophilic fasciitis induced by checkpoint inhibitors: A retrospective multicenter case series, comparison with eosinophilic fasciitis unrelated to checkpoint inhibition and literature review.

Journal: Journal of the American Academy of Dermatology

Published: March 21, 2026

Prognostic classification of skin adnexal carcinomas: Results from a prospective study of 980 patients in the French CARADERM network.

Prognostic classification of skin adnexal carcinomas: Results from a prospective study of 980 patients in the French CARADERM network.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 22, 2026

DHODH inhibition suppresses cutaneous squamous cell carcinoma growth by the induction of differentiation through perturbation of the cellular redox balance.

DHODH inhibition suppresses cutaneous squamous cell carcinoma growth by the induction of differentiation through perturbation of the cellular redox balance.

Journal: Cell death & disease

Published: November 22, 2025

Genomic and clinical characterization of anogenital basal cell carcinoma: A retrospective and prospective cohort study.

Genomic and clinical characterization of anogenital basal cell carcinoma: A retrospective and prospective cohort study.

Journal: Journal of the American Academy of Dermatology

Published: February 12, 2025

Immune Checkpoint Inhibitors in Field Cancerization and Keratinocyte Cancer Prevention.

Immune Checkpoint Inhibitors in Field Cancerization and Keratinocyte Cancer Prevention.

Journal: JAMA dermatology

Published: February 12, 2025

Metabolism-based scoring of cutaneous squamous cell carcinoma to predict tumour features and responses to treatment with dihydroorotate dehydrogenase inhibitors.

Metabolism-based scoring of cutaneous squamous cell carcinoma to predict tumour features and responses to treatment with dihydroorotate dehydrogenase inhibitors.

Journal: The British journal of dermatology

Published: January 22, 2025

A new frontier in drug discovery for skin cancer through electronic medical records.

A new frontier in drug discovery for skin cancer through electronic medical records.

Journal: The British journal of dermatology

Published: December 06, 2024

Immune signatures across different stages of cutaneous squamous cell carcinoma.

Immune signatures across different stages of cutaneous squamous cell carcinoma.

Journal: Journal of dermatological science

Published: September 02, 2024

Trial protocol for SiroSkin: a randomised double-blind placebo-controlled trial of topical sirolimus in chemoprevention of facial squamous cell carcinomas in solid organ transplant recipients.

Trial protocol for SiroSkin: a randomised double-blind placebo-controlled trial of topical sirolimus in chemoprevention of facial squamous cell carcinomas in solid organ transplant recipients.

Journal: Trials

Published: August 26, 2024

Energy metabolism rewiring following acute UVB irradiation is largely dependent on nuclear DNA damage.

Energy metabolism rewiring following acute UVB irradiation is largely dependent on nuclear DNA damage.

Journal: Free radical biology & medicine

Published: August 21, 2024

Tyrosine kinase inhibitors in cancers: Treatment optimization - Part II.

Tyrosine kinase inhibitors in cancers: Treatment optimization - Part II.

Journal: Critical reviews in oncology/hematology

Published: January 24, 2024

Tyrosine kinase inhibitors in cancers: Treatment optimization - Part I.

Tyrosine kinase inhibitors in cancers: Treatment optimization - Part I.

Journal: Critical reviews in oncology/hematology

Published: January 24, 2024

Showing 1-12 of 47

Last Updated: 09/26/2026